Hot Features
Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company engaged in discovering and developing therapies to address the unmet medical needs of patients with severe viral diseases. Its programs are focused on the development of orally- administered direct acting antivirals for the treat... Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company engaged in discovering and developing therapies to address the unmet medical needs of patients with severe viral diseases. Its programs are focused on the development of orally- administered direct acting antivirals for the treatment of patients with COVID-19 in the hospital and community settings, the treatment of patients with chronic hepatitis C infection, the treatment of patients with dengue, and the treatment of high-risk patients with severe respiratory syncytial virus infection. The company's medicinal chemistry, virology, and pharmacology expertise, bolstered by its collective experience in drug development, enables it to pioneer new advancements in antiviral science. Mehr anzeigen
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.135 | -4.41898527005 | 3.055 | 3.055 | 2.88 | 318276 | 2.94969838 | CS |
| 4 | -0.11 | -3.6303630363 | 3.03 | 3.25 | 2.88 | 299636 | 3.0485819 | CS |
| 12 | -0.315 | -9.7372488408 | 3.235 | 3.599 | 2.88 | 427725 | 3.15977383 | CS |
| 26 | -0.79 | -21.2938005391 | 3.71 | 4.145 | 2.3 | 311337 | 3.25705762 | CS |
| 52 | -1.08 | -27 | 4 | 4.18 | 2.3 | 283555 | 3.47443401 | CS |
| 156 | -3.31 | -53.1300160514 | 6.23 | 9.79 | 2.3 | 452322 | 4.67483589 | CS |
| 260 | 2.0975 | 255.015197568 | 0.8225 | 94.1737 | 0.8225 | 819420 | 14.75954883 | CS |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
